# Study on the Diagnostic Value of Novel PET Molecular Imaging for Renal Cell Carcinoma

> **NCT07301827** · NA · RECRUITING · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 66 (estimated)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **DRUG:** [68Ga]Ga-DOTA-CAIX peptide
- **DRUG:** [68Ga]Ga-NOTA-CD70 antibody fragment
- **DRUG:** [68Ga]Ga-PSMA

## Key facts

- **NCT ID:** NCT07301827
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2025-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07301827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07301827, "Study on the Diagnostic Value of Novel PET Molecular Imaging for Renal Cell Carcinoma". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT07301827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*